Shri Dinesh Mills board approved demerging its FELT business and proposed a final dividend of ₹1.50. Revenue grew marginally, but profits declined due to higher overheads.
Shri Dinesh Mills Ltd. Approves FELT Business Demerger and Proposes Dividend
Revenue from operations for Shri Dinesh Mills Ltd. reached ₹67.33 crore, a marginal increase of 1.55% from the previous year's ₹66.30 crore. Profit after tax, however, saw a decline of 16.48%, falling to ₹8.77 crore from ₹10.50 crore.
Reader Takeaway: Demerger planned, but profit margins face pressure from rising overheads.
What just happened
Shri Dinesh Mills Ltd. announced a series of corporate actions and financial results. The company's board granted in-principle approval for demerging its FELT (Technical Textiles) business into a separate entity. Concurrently, they proposed a final dividend of ₹1.50 per share. The company also reported a marginal increase in revenue from operations but a significant decrease in profit after tax due to higher overhead expenses.
Why this matters
The demerger aims to create a distinct entity for the FELT business, potentially unlocking value and allowing for focused management. The proposed dividend offers a direct return to shareholders. However, the decline in profitability due to increased overheads and external market factors highlights a challenge the company needs to address.
The backstory
In the previous financial year, Shri Dinesh Mills Ltd. reported revenue of ₹66.30 crore and a profit after tax of ₹10.50 crore. The company also completed the divestment of its entire shareholding in Dinesh Remedies Ltd. in September 2025, ceasing it to be a subsidiary. The current financial year's results show continued revenue growth, albeit slower, but a notable pressure on profits.
What changes now
The demerger of the FELT business will require further regulatory approvals, including from the National Company Law Tribunal (NCLT). The company has already segregated its FELT and Residual business verticals for interim management. The company also has a new statutory auditor proposed for a five-year term.
Risks to watch
The primary risks include the successful navigation of the NCLT and regulatory approval process for the demerger. The company also faces the challenge of managing increasing overhead expenses, which are currently compressing profit margins. Dependence on imported raw materials and potential global market disruptions are also noted concerns.
Peer comparison
(No peer comparison data available in the filing)
Context metrics (time-bound)
Revenue from operations: ₹67.33 crore in FY 2025-2026, up 1.55% from ₹66.30 crore in FY 2024-2025.
Profit After Tax: ₹8.77 crore in FY 2025-2026, down 16.48% from ₹10.50 crore in FY 2024-2025.
Total Comprehensive Income: ₹8.50 crore in FY 2025-2026, down 12.46% from ₹9.71 crore in FY 2024-2025.
Proposed Final Dividend: ₹1.50 per share.
Divestment of Dinesh Remedies Ltd. completed: September 3, 2025.
What to track next
Investors should monitor the progress of the FELT business demerger, including NCLT proceedings and approvals. The company's ability to control overhead costs and mitigate risks associated with global market disruptions will be crucial for future profitability.